Alpha-Synuclein is Involved in DYT1 Dystonia Striatal Synaptic Dysfunction

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Alpha-synuclein (α-Syn) is central to Parkinson's disease.
• TorsinA (TA), linked to DYT1 dystonia, interacts with α-Syn and accumulates in Lewy bodies.
• The role of α-Syn in dystonia remains unexplored.

Purpose of the Study:

• Investigate α-Syn and SNARE protein involvement in DYT1 dystonia synaptic dysfunction.
• Explore the relationship between α-Syn, TA, and synaptic alterations in DYT1 dystonia.

Main Methods:

• Utilized electrophysiological and biochemical techniques.
• Studied synaptic alterations in the dorsal striatum of the Tor1a+/Δgag mouse model of DYT1 dystonia.

Main Results:

• Reduced α-Syn levels were observed in the striata of DYT1 mutant mice, particularly in glutamatergic terminals.
• Striatal levels of VAMP-2 and SNAP-23 (SNARE proteins) were significantly decreased in mutant mice.
• Impaired miniature glutamatergic postsynaptic currents (mEPSCs) and altered release probability were detected, alongside reduced TA expression in α-Syn null mice.

Conclusions:

• Established an unprecedented relationship between torsinA (TA) and alpha-synuclein (α-Syn).
• Demonstrated that α-Syn and SNARE protein alterations are characteristic of synaptic dysfunction in DYT1 dystonia.
• Highlighted a novel molecular mechanism underlying DYT1 dystonia pathophysiology.